Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jan 25 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jan-25-2024-1

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 25, 2024, titled "Zydus receives Final Approval from the USFDA for Gabapentin Tablets (Once-Daily), 300 mg and 600 mg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases